or your assessment of Winnipeg’s depth chart.) Either way, two-thirds of you want Pionk preserved. Since that same number of you wanted him traded last summer, I guess he’s impressed you with his ...
The following is a summary of “Parenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional ...
SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the RESET Clinical Trial’s Primary Endpoint, ...